Axsome Therapeutics, Inc.Axsome Therapeutics, Inc.Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc.

No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −1.26 USD per share, beating the −0.84 USD estimate by −49.22%. Revenue for the same period reached ‪189.40 M‬ USD, despite the estimate of ‪190.91 M‬ USD. For the next quarter, analysts expect −0.84 USD in earnings per share and ‪222.25 M‬ USD in revenue.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise